Regulatory T (Treg) cells maintain immune homeostasis by inhibiting excessive immune responses. Treg cells control a variety of immune responses, which vary according to the nature of the infection or insult. Treg cells were once thought to be stable; however, many studies now suggest that they have a certain level of flexibility, or plasticity. For example, they deal with various inflammatory conditions by adapting to the environment. Treg cells controlling type I responses express T-bet 1 or IRF8, 2 whereas those controlling type II responses express IRF4, 3 those controlling type III responses express STAT3, 4 and those controlling germinal center reactions express Bcl-6. 5, 6 In addition, Treg cells residing in visceral adipose tissue express PPAR-γ, 7 whereas those residing in skeletal muscle express amphiregulin. 8 These tissue-resident Treg cells have specialized roles, including the control of metabolic inflammation and muscle repair. 7, 8 9, 10 However, other studies using the same technique show that Treg cells can lose both Foxp3 expression and suppressive activity under autoimmune and inflammatory conditions. 11, 12 Th1-like Treg cells can be generated by stimulation under the influence of IL-12 in vitro. 13 The resulting cells produce IFN-γ and induce expression of T-bet and Th1-specific markers such as CXCR3 and CCR5. 13 Several studies report that Th1-like Treg cells are generated in vivo. 14, 15 16 IL-12 is thought to play a role in destabilizing Treg cells, as it inhibits proliferation, suppressive activity, and expression of Foxp3 and CD25 in vitro. 13 However, prolonged exposure to IFN-γ induces IL-12R β2 expression by Treg cells, rendering them responsive to IL-12.
17 IFN-γ also plays a positive or negative role in the induction of suppressive Th1-like Treg cells. During Mycobacterium infection, IFN-γ induces T-betexpressing Treg cells, which suppress type I responses. 1 In contrast, prolonged exposure of IFN-γ induces IL-12R β2 and destabilizes suppressive Th1-like Treg cells. 17 TNF-α also plays a dual role in Th1-like Treg cells. TNF-α induces OX40, which induces Treg cell activation and strengthens suppressive activity. 18 TNF-α plays a role in stabilizing Treg cell function in mouse models of colitis and diabetes; 14, 15 however, other studies show that TNF-α reduces Foxp3 expression and inhibits Treg suppressive activity. 14, 15 In addition, blocking TNF-α in those with rheumatoid arthritis induces suppressive Treg cells. 14, 15 Taken together, these data suggest that the role of type I cytokines may not be one-sided; rather, the magnitude and duration of the cytokines are important for determining the suppressive activity of Th1-like Treg cells. Based on these results, I propose that during the resolution phase of acute type I responses, suppressive Th1-like Treg cells are generated by Th1 cytokines as a feedback mechanism to prevent immune pathology. In contrast, during the chronic phase of type I responses (such as chronic infection or autoimmunity), Th1-like Treg cells lose their suppressive function due to continuous stimulation by type I cytokines (Fig. 1) .
Factors other than cytokines may be involved in regulating Th1-like Treg cell function. In a previous study, we showed that the transcription factor IRF8 controls type I immune responses.
2 IRF8-deficient Treg cells show aberrant expression of Th2 and Th17 cytokines, are defective in CXCR3 expression, and cannot migrate to Th1 inflammatory sites. 2 During type I immune responses, IRF8 expression in Treg cells increases in a manner similar to that of Tbet and CXCR3; however, IRF8 does not affect T-bet expression. IRF8-deficient Treg cells cannot control Th1-mediated immune responses in a collagen-induced arthritis model. 2 Another study showed that T-bet expressed by Treg cells is important for controlling type I immune responses. 1 Thus, multiple independent mechanisms may work to control type I immune responses. In contrast to T-bet, IRF8 is highly expressed by Treg cells, 2 suggesting that it plays a specific role in Treg cell function. Two papers published recently support a role for IRF8 in Treg cell function. 19, 20 In agreement with our own study, Lin et al. showed that IRF8 is important for the suppressive function and identity of Treg cells. 19 Lin et al. showed that ubiquitin-specific protease (USP) 4 interacts physically with IRF8 to promote K-48-linked deubiquitination, thereby stabilizing IRF8. 19 shRNA-mediated knock-down of USP4 or its inhibition by Vialilin A reduces IRF8 protein levels and causes aberrantly high expression of Th2 (IL-4, IL-5, and IL-13) and Th17 (IL-21) cytokines in Treg cells; this causes Treg cells to lose suppressive function. 19 Carr et al. showed that transcription factor JunB activates expression of Th17 lineagespecific genes and represses Th1 and Treg cells. 20 JunB exerts this effect, in part, by limiting expression of IRF8. 20 These results suggest that IRF8 may act as an identity-keeper for Th1-suppressing Treg cells. It is tempting to speculate that, when IRF8 is present, Th1-suppressing Treg function is intact but that the suppressive function is compromised in its absence. This notion of an identity-keeper is interesting because it suggests that T-bet and IRF8 may play different roles in Treg cells. T-bet expression is induced by type I immune responses, whereas IRF8 expression is constitutively high in Treg cells. Expression of IRF8 is influenced by both Th1-inducing and Treg-inducing conditions, suggesting that it has a specialized role under each circumstance. However, T-bet expression is induced under Th1-inducing conditions regardless of Treg-inducing conditions. Thus, I propose that IRF8 may serve as an identity-keeper for suppressive Th1-like Treg cells (Fig. 1) . 
